DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Rittmeyer A. et al.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
The Lancet 2017;
389: 255-265
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.